Notice of Results

As announced on 28 January 2015, EKF Diagnostics Holdings plc, the AIM listed point-of-care, central laboratory and molecular diagnostics business, will announce its preliminary results for the year ended 31 December 2014 on Monday 16 March 2015.

Analyst presentation

A briefing for analysts will take place at the London Capital Club, 15 Abchurch Lane, EC4N 7BW at 9.30am on Monday 16 March 2015.

Investor presentation

A briefing for all investors will take place on Tuesday 17 March 2015 at Rocket, 6 Adams Court, Old Broad Street, London EC2N 1DX from 4:30pm for a 4.45pm start, and will be followed by drinks and canapés.

If you would like to register to attend either presentation, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com.

Back to Listing Previous Next

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.